Non-Hodgkin’s lymphoma treatment in early pregnancy: dilemmas between risks and benefits

Keyphrases

• Non-Hodgkin Lymphoma 100%
• Early Pregnancy 100%
• Lymphoma Therapy 100%
• Pregnant Women 66%
• Chemotherapy 66%
• Malignancy 33%
• Negative Effects 33%
• Fetus 33%
• During Pregnancy 33%
• Computed Tomography 33%
• Immunohistochemistry 33%
• Outpatient Clinic 33%
• Heart Rate 33%
• Academic Hospital 33%
• Sitting Position 33%
• Doxorubicin 33%
• Cesarean Section (C-section) 33%
• 13th 33%
• Shortness of Breath 33%
• Chemotherapy Regimen 33%
• Body Surface Area 33%
• Hospital Admission 33%
• Cyclophosphamide 33%
• Prednisone 33%
• Fine-needle Aspiration Biopsy 33%
• Microcytic Hypochromic Anemia 33%
• Second Trimester 33%
• CHOP Chemotherapy 33%
• Older Pregnant Women 33%
• Oncology Outpatients 33%
• Night Sweats 33%
• Live Baby 33%
• Superior Vena Cava Syndrome 33%
• Obstetric Ultrasound 33%
• Medical Complications 33%
• Patient's Sleep 33%
• One-stop 33%
• Firm Boundaries 33%
• First Semester 33%

Medicine and Dentistry

• Non-Hodgkin Lymphoma 100%
• First Trimester Pregnancy 100%
• Neck 66%
• Case Presentation 33%
• Dyspnea 33%
• Cancer 33%
• CHOP 33%
• Immunohistochemistry 33%
• Outpatient 33%
• Oncology 33%
• Cesarean Section 33%
• Cytotechnology 33%
• Fine-Needle Aspiration 33%
• Body Weight 33%
• Body Surface 33%
• Hypochromic Anemia 33%
• Doxorubicin 33%
• Cyclophosphamide 33%
• Prednisone 33%
• Chemotherapy Regimens 33%
• Vincristine 33%
• Sitting 33%
• Second Trimester Pregnancy 33%
• Night Sweat 33%
• Superior Vena Cava Syndrome 33%
• Obstetric Ultrasonography 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Nonhodgkin Lymphoma 100%
• Chemotherapy 66%
• Doxorubicin 33%
• Dyspnea 33%
• Cyclophosphamide 33%
• Prednisone 33%
• Chemotherapy Regimens 33%
• Vincristine 33%
• Iron Deficiency Anemia 33%
• Night Sweat 33%
• Superior Cava Vein Syndrome 33%